| |
| |
|
| Insider
Information: |
Rosenbaum David P. |
| Relationship: |
|
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
378,985 |
|
|
Indirect Shares
|
253,528 |
|
|
| Direct
Value |
$2,963,663 |
|
|
|
Indirect Value
|
$1,982,589 |
|
|
| Total
Shares |
632,513 |
|
|
| Total
Value |
$4,946,252 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
33
|
|
Stock
price went up :
|
1
|
23
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
2.3
|
| Percentage
Gain/Loss : |
 276.6%
|
3,078.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardelyx Inc |
ARDX |
|
2024-02-26 |
378,985 |
2024-02-26 |
253,528 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARDX |
Ardelyx Inc |
VP, Drug DevelopmentOfficer |
• – – |
2014-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,880 |
|
- |
|
| ARDX |
Ardelyx Inc |
VP, Drug DevelopmentOfficer |
• – – |
2014-06-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
85,923 |
|
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-05-20 |
4 |
S |
$7.09 |
$1,113 |
I/I |
(157) |
29,812 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-08-20 |
4 |
S |
$1.32 |
$232 |
I/I |
(176) |
26,574 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-11-22 |
4 |
S |
$0.99 |
$182 |
I/I |
(184) |
90,627 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-02-22 |
4 |
S |
$6.88 |
$1,328 |
I/I |
(193) |
29,969 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-11-22 |
4 |
S |
$1.94 |
$943 |
I/I |
(484) |
88,885 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-08-22 |
4 |
S |
$0.98 |
$489 |
I/I |
(497) |
89,369 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-05-20 |
4 |
S |
$0.67 |
$352 |
I/I |
(524) |
107,502 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-22 |
4 |
AS |
$22.00 |
$13,200 |
D/D |
(600) |
73,652 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-22 |
4/A |
AS |
$22.00 |
$13,200 |
D/D |
(600) |
21,940 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-02-22 |
4 |
S |
$0.67 |
$403 |
I/I |
(601) |
105,026 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-02-22 |
4 |
S |
$6.88 |
$4,212 |
D/D |
(612) |
165,047 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-05-20 |
4 |
S |
$7.09 |
$4,338 |
D/D |
(612) |
159,435 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-08-20 |
4 |
S |
$1.32 |
$833 |
D/D |
(631) |
158,804 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-11-22 |
4 |
S |
$0.99 |
$638 |
D/D |
(643) |
311,161 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-21 |
4/A |
AS |
$22.09 |
$17,674 |
D/D |
(800) |
22,540 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-21 |
4 |
AS |
$22.09 |
$17,674 |
I/I |
(800) |
74,252 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2019-01-02 |
4 |
S |
$1.70 |
$1,363 |
I/I |
(801) |
18,029 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2016-12-16 |
4 |
S |
$14.48 |
$13,035 |
I/I |
(900) |
636 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-11-20 |
4 |
S |
$4.36 |
$4,066 |
I/I |
(932) |
113,293 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-05-23 |
4 |
S |
$3.65 |
$3,412 |
I/I |
(934) |
112,162 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-08-21 |
4 |
S |
$3.55 |
$3,328 |
I/I |
(937) |
111,225 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2017-03-10 |
4 |
S |
$13.48 |
$13,482 |
I/I |
(1,000) |
1,277 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-02-21 |
4 |
S |
$3.00 |
$3,343 |
I/I |
(1,114) |
113,096 |
0 |
% |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
